摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-chloro-4-fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridine | 372122-57-1

中文名称
——
中文别名
——
英文名称
2-(2-chloro-4-fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridine
英文别名
2-(2-Chloro-4-fluorophenyl)-6-(trifluoromethyl)pyrazolo[1,5-A]pyridine
2-(2-chloro-4-fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridine化学式
CAS
372122-57-1
化学式
C14H7ClF4N2
mdl
——
分子量
314.67
InChiKey
RLYKPEJKIFEIDE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    17.3
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    在 iron(II) chloride 作用下, 以 乙二醇二甲醚 为溶剂, 反应 16.0h, 生成 2-(2-chloro-4-fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridine
    参考文献:
    名称:
    PROCESS FOR THE PREPARATION OF CHEMICAL COMPOUNDS
    摘要:
    该发明提供了一种制备式(I)化合物及其药学上可接受的衍生物的过程,其中:R0和R1独立地选自H、卤素、C1-6烷基、C1-6烷氧基或C1-6烷氧基,其被一个或多个氟原子取代;R2为H、C1-6烷基、C1-6烷基被一个或多个氟原子取代、C1-6烷氧基、C1-6羟基烷基、SC1-6烷基、C(O)H、C(O)C1-6烷基、C1-6烷基磺酰基、C1-6烷氧基被一个或多个氟原子取代、卤素、CN、CONR4R5、CO2H、CO2C1-6烷基或NHSO2R4,R3为H或苯基,其被SO2C1-6烷基或SO2NH2取代;R4和R5独立地选自H、C1-6烷基、苯基、苯基被一个或多个原子或基团R6取代,或与它们所连接的氮原子一起形成饱和的4到8个成员环;R6为卤素、C1-6烷基、C1-6烷氧基或C1-6烷氧基,其被一个或多个氟原子取代;该过程包括在催化剂和溶剂的存在下重排式(11)的环氮丙烷或其保护衍生物,其中R0到R3如式(I)所定义,或其保护衍生物。
    公开号:
    US20030212275A1
点击查看最新优质反应信息

文献信息

  • Process for the preparation of chemical compounds
    申请人:SmithKline Beecham Corporation
    公开号:US06756498B2
    公开(公告)日:2004-06-29
    The invention provides a process for preparing a compound of formula (I) and pharmaceutically acceptable derivatives thereof wherein: R0 and R1 are independently selected from H, halogen, C1-6alkyl, C1-6alkoxy, or C1-6alkoxy substituted by one or more fluorine atoms; R2 is H, C1-6alkyl, C1-6alkyl substituted by one or more fluorine atoms, C1-6alkoxy, C1-6hydroxyalkyl, SC1-6alkyl, C(O)H, C(O)C1-6alkyl, C1-6alkylsulfonyl, C1-6alkoxy substituted by one or more fluorine atoms, halogen, CN, CONR4R5, CO2H, CO2C1-6alkyl, or NHSO2R4; R3 is H or phenyl substituted by SO2C1-6alkyl or SO2NH2; R4 and R5 are independently selected from H, C1-6alkyl, phenyl, phenyl substituted by one or more atoms or groups R6, or together with the nitrogen atom to which they are attached form a saturated 4 to 8 membered ring R6 is halogen, C1-6alkyl, C1-6alkoxy or C1-6alkoxy substituted by one or more fluorine atoms; which comprises rearrangement of an azirine of formula (II)  wherein R0 to R3 are as defined for formula (I), or a protected derivative thereof, in the presence of a catalyst and a solvent.
    这项发明提供了一种制备式(I)化合物及其药学上可接受的衍生物的过程,其中:R0和R1独立地选择自H,卤素,C1-6烷基,C1-6烷氧基或C1-6烷氧基上被一个或多个氟原子取代的基团;R2是H,C1-6烷基,C1-6烷基上被一个或多个氟原子取代,C1-6烷氧基,C1-6羟基烷基,SC1-6烷基,C(O)H,C(O)C1-6烷基,C1-6烷基磺酰基,C1-6烷氧基上被一个或多个氟原子取代,卤素,CN,CONR4R5,CO2H,CO2C1-6烷基或NHSO2R4;R3是H或苯基上被SO2C1-6烷基或SO2NH2取代;R4和R5独立地选择自H,C1-6烷基,苯基,苯基上被一个或多个原子或基团R6取代,或者与它们连接的氮原子形成饱和的4到8环;R6是卤素,C1-6烷基,C1-6烷氧基或C1-6烷氧基上被一个或多个氟原子取代的基团;该过程包括在催化剂和溶剂的存在下重排式(II)的环氧丙烷,其中R0到R3与式(I)中定义的相同,或者它们的保护衍生物。
  • PROCESS FOR THE PREPARATION OF PYRAZOLOPYRIDINE DERIVATIVES
    申请人:GLAXO GROUP LIMITED
    公开号:EP1276742A2
    公开(公告)日:2003-01-22
  • US6756498B2
    申请人:——
    公开号:US6756498B2
    公开(公告)日:2004-06-29
  • [EN] PROCESS FOR THE PREPARATION OF CHEMICAL COMPOUNDS<br/>[FR] PROCEDE DE PREPARATION DE COMPOSES CHIMIQUES
    申请人:GLAXO GROUP LTD
    公开号:WO2001083479A2
    公开(公告)日:2001-11-08
    The invention provides a process for preparing a compound of formula (I) and pharmaceutically acceptable derivatives thereof wherein: R?o and R1¿ are independently selected from H, halogen, C¿1-6?alkyl, C1-6alkoxy, or C1-6alkoxy substituted by one or more fluorine atoms; R?2¿ is H, C¿1-6?alkyl, C1-6alkyl substituted by one or more fluorine atoms, C1-6alkoxy, C1-6hydroxyalkyl, SC1-6alkyl, C(O)H, C(O)C1-6alkyl, C1-6alkylsulfonyl, C1-6alkoxy substituted by one or more fluorine atoms, halogen, CN, CONR?4R5, CO¿2H, CO2C1-6alkyl, or NHSO2R4; R3 is H or phenyl substituted by SO¿2?C1-6alkyl or SO2NH2; R?4 and R5¿ are independently selected from H, C¿1-6?alkyl, phenyl, phenyl substituted by one or more atoms or groups R?6¿, or together with the nitrogen atom to which they are attached form a saturated 4 to 8 membered ring R6 is halogen, C¿1-6?alkyl, C1-6alkoxy or C1-6alkoxy substituted by one or more fluorine atoms; which comprises rearrangement of an azirine of formula (II) wherein R?0 to R3¿ are as defined for formula (I), or a protected derivative thereof, in the presence of a catalyst and a solvent.
  • PROCESS FOR THE PREPARATION OF CHEMICAL COMPOUNDS
    申请人:——
    公开号:US20030212275A1
    公开(公告)日:2003-11-13
    The invention provides a process for preparing a compound of formula (I) and pharmaceutically acceptable derivatives thereof wherein: R 0 and R 1 are independently selected from H. halogen, C 1-6 alkyl, C 1-6 alkoxy. or C 1-6 alkoxy substituted by one or more fluorine atoms; R 2 is H, C 1-6 alkyl. C 1-6 alkyl substituted by one or more fluorine atoms. C 1-6 alkoxy, C 1-6 hydroxyalkyl. SC 1-6 alkyl. C(O)H. C(O)C 1-6 alkyl. C 1-6 alkylsulfonyl. C 1-6 alkoxy substituted by one or more fluorine atoms, halogen. CN, CONR 4 R 5 , CO 2 H, CO 2 C 1-6 alkyl, or NHSO 2 R 4 , R 3 is H or phenyl substituted by SO 2 C 1-6 alkyl or SO 2 NH 2 : R 4 and R 5 are independently selected from H, C 1-6 alkyl, phenyl, phenyl substituted by one or more atoms or groups R 6 , or together with the nitrogen atom to which they are attached form a saturated 4 to 8 membered ring R 6 is halogen, C 1-6 alkyl, C 1-6 alkoxy or C 1-6 alkoxy substituted by one or more fluorine atoms; which comprises rearrangement of an azirine of formula (11) wherein R 0 to R 3 are as defined for formula (I), or a protected derivative thereof, in the presence of a catalyst and a solvent. 1
    该发明提供了一种制备式(I)化合物及其药学上可接受的衍生物的过程,其中:R0和R1独立地选自H、卤素、C1-6烷基、C1-6烷氧基或C1-6烷氧基,其被一个或多个氟原子取代;R2为H、C1-6烷基、C1-6烷基被一个或多个氟原子取代、C1-6烷氧基、C1-6羟基烷基、SC1-6烷基、C(O)H、C(O)C1-6烷基、C1-6烷基磺酰基、C1-6烷氧基被一个或多个氟原子取代、卤素、CN、CONR4R5、CO2H、CO2C1-6烷基或NHSO2R4,R3为H或苯基,其被SO2C1-6烷基或SO2NH2取代;R4和R5独立地选自H、C1-6烷基、苯基、苯基被一个或多个原子或基团R6取代,或与它们所连接的氮原子一起形成饱和的4到8个成员环;R6为卤素、C1-6烷基、C1-6烷氧基或C1-6烷氧基,其被一个或多个氟原子取代;该过程包括在催化剂和溶剂的存在下重排式(11)的环氮丙烷或其保护衍生物,其中R0到R3如式(I)所定义,或其保护衍生物。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺